David M. Epstein
2022
In 2022, David M. Epstein earned a total compensation of $1.6M as President and Chief Executive Officer at Black Diamond Therapeutics, a 68% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $310,436 |
|---|---|
| Option Awards | $759,775 |
| Salary | $554,350 |
| Other | $20,296 |
| Total | $1,644,857 |
Epstein received $759.8K in option awards, accounting for 46% of the total pay in 2022.
Epstein also received $310.4K in non-equity incentive plan, $554.4K in salary and $20.3K in other compensation.
Rankings
In 2022, David M. Epstein's compensation ranked 2,073rd out of 5,760 executives tracked by ExecPay. In other words, Epstein earned more than 64.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,073 out of 5,760 | 64th |
Division Manufacturing | 1,116 out of 3,136 | 64th |
Major group Chemicals And Allied Products | 477 out of 1,422 | 67th |
Industry group Drugs | 438 out of 1,323 | 67th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 291 | 64th |
Source: SEC filing on April 4, 2023.
Epstein's colleagues
We found two more compensation records of executives who worked with David M. Epstein at Black Diamond Therapeutics in 2022.